Skip to content

歐嘉隆台灣 logo

Main menu
    • 我們的故事
    • 了解我們名字的由來
    • 願景、使命和價值觀
    • 多元性、公平性和包容性
    • 環境保護、社會責任和企業治理
    • 我們的重點領域
    • 產品列表
    • Nasonex 內舒拿小藍瓶
  • 新聞
  • 歐嘉隆台灣
  • 加入我們

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
     

為女性的健康而生

我們期望為每位女性創造更好、更健康的每一天

為什麼我們會在這裡?

我們相信每一位女性都值得擁有更好、更健康的每一天。我們也相信一個更健康的世界是以女性健康作為基礎。作為一家新公司,我們將首先傾聽女性所有的醫療保健需求,使我們能夠開發適合她們的治療方法-因為我們知道我們可以為女性及其健康做更多的事情。

了解我們

TW-NON-110215 Dec/2024

我們專注的領域

我們在生殖醫學、心臟疾病、皮膚病、過敏和氣喘等一系列領域擁有 60 多種藥物和其他產品的強大基礎。我們將這些重要的療法帶到世界各地,足跡遍布全球,為 140 多個市場的民眾提供服務。

了解更多我們專注的領域
女性健康藥品


女性的健康

我們知道女性在醫療保健方面需要有更多選擇。透過我們專門為滿足她們的需求而設計的產品組合,我們的目標是為每位女性創造更好、更健康的每一天。

生物相似性藥品

(僅供參考,

台灣並無相關產品)

藉由提供生物相似性藥品(僅供參考,台灣並無相關產品)作為一種重要的治療選擇,我們旨在為更多需要它們的患者帶來更多選擇。

既有品牌藥品

我們的既有品牌藥品組合歷史悠久,涵蓋心血管、呼吸道、皮膚科和非鴉片類疼痛控制藥物等關鍵領域。

職涯

我們共同努力解決對女性最重要的醫療保健問題

我們的員工-一個由數千人組成的全球團隊-團結一致,致力於更好地支持我們公司內部和全球女性的健康

加入我們的團隊

媒體

了解有關 Organon歐嘉隆 的所有最新消息

閱讀我們的最新消息

荷蘭商歐嘉隆有限公司台灣分公司

週一至週五 9:00-17:30

聯絡資訊
臺北市信義區松仁路97號4樓

(02) 8758-3650

dpoc.taiwan@organon.com

TW-NON-110191 Oct/2024

歐嘉隆台灣 logo
  • Cookie 政策
  • 隱私權政策
  • 使用條款
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept